A US appeals court has thrown out a jury verdict against a South Korean medical device company, ruling that Insulet waited too long to bring its trade secret misappropriation claim.

A senior pharmaceutical lawyer, with experience across private practice and Big Pharma, joins the company after a decade-long tenure at Teva.

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

AbbVie’s trade secret suit against a Chinese rival gets green light ...

In the firm’s second IP conflict dispute in a year, a healthcare tech company claims Kirkland lawyers "committed the cardinal ...

Orrick lands five-member M&A team in Paris ...

The award could rise to several billions under federal antitrust law, after the pharma company was found to have engaged in anticompetitive conduct over constipation drug Amitiza.

The court has imposed a financial penalty after finding it continued promoting banned devices online despite an injunction covering five European countries.

LSIPR's senior reporter Marisa Woutersen speaks with Ben Doranz of Integral Molecular, fresh from the stage at LSPN Boston after speaking at a panel session on challenges in antibody patent protection ...

J&J’s Abiomed can proceed with its non-infringement defence despite potential future appellate reversal, in a week when both parties in the case were dealt wins and losses in their clash over Impella ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

The agreement is the latest in a string of major deals between Hengrui and multinational drugmakers, and will see the parties jointly develop assets while licensing others.